Review Article

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis

Table 2


StudyDemographicsRisk factors ()Indications ()
CohortAgeMale ()HTNDMSmokeDyslipidaemiaPrevious MIPrevious CABGUAPSAPNSTEMISilent ischaemia

Marquis-Gravel et al. [14]Overall6514565145NR91NRNRNRNR145NR
Adriaenssens et al. [15]DEB67.6 ± 7.71816652412NR51316
DES64.2 ± 112515132410NR51712
Alfonso et al. [16]DEB67 ± 1182683056695743843NR14
DES64 ± 1282681970625674241NR11
Almalla et al. [17]DEB69.6 ± 9.638371814NR1710NRNRNRNR
DES67.7 ± 10.828341421NR214NRNRNRNR
Naganuma et al. [18]DEB67.2 ± 10.467522955434141756 (including silent ischaemia and SAP)NRNR
DES65.2 ± 10.174613266945171471 (including silent ischaemia and SAP)NRNR
Kubo et al. [19]DEB69.7 ± 9.73230182824196NRNRNRNR
DES71.3 ± 8.84141263637286NRNRNRNR
Alfonso et al. [20]DEB66 ± 10127110758911073168074 (including silent ischaemia)NRNR
DES66 ± 10130121668712177177979 (including silent ischaemia)NRNR
Kang et al. [21]DEB63.1 ± 9.81251328085165NRNR60NRNRNR
DES59.5 ± 11.03639162646NRNR24NRNRNR
Basavarajaiah et al. [22]DEB66.8 ± 9.07358387593025NRNRNRNR
DES65.7 ± 9.614311955121278556NRNRNRNR
Kawamoto et al. [23]DEB64.9 ± 9.15751286513617NRNRNRNR
DES67.2 ± 8.96354289544227NRNRNRNR
Pleva et al. [24]DEB65.6 ± 10.943NR17NRNR433NR23 (including STEMI)243
DES65.5 ± 10.646NR18NRNR416NR18 (including STEMI)2510
Cui et al. [25]DEB61.9 ± 9.056563935382567NRNRNR
DES61.5 ± 9.5826843504732211NRNRNR

HTN: hypertension; DM: diabetes mellitus; MI: myocardial infarction; CABG: coronary artery bypass graft; UAP: unstable angina pectoris; SAP: stable angina pectoris; NSTEMI: non-ST elevation myocardial infarction.